DEVICE-BASED RISK MANAGEMENT OF A THERAPEUTIC

Patent №

US 11,830,615

Granted

2023-11-28

Filed 2019

Owner

OTSUKA PHARMACEUTICAL CO., LTD.

+2 more

Lab

AI components

2

kr · planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16518164

A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.

Knowledge representationPlanningG16H 40/67G06Q 10/10G06Q 10/101G06Q 10/105G06Q 50/265G16H 10/60G16H 20/10G16H 50/20+2 more

AI classification

Knowledge representation1.00
Planning0.98
AI hardware0.01
Natural language0.01
Machine learning0.00
Vision0.00
Speech0.00
Evolutionary computation0.00

Ownership

OTSUKA PHARMACEUTICAL CO., LTD.

assignment · 587440793

OTSUKA AMERICA PHARMACEUTICAL, INC.

assignment · 587440884

OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.

assignment · 587450086

© 2026 NYSGPT2525 LLC